The Canadian Centre for Ethics in Sport (CCES) announced Wednesday that cyclist Arnaud Papillon has received a two-year sanction for the use of erythropoietin (EPO) during the Canadian Road Championships.
One in-competition sample and one out-of competition sample “returned adverse analytical findings for the presence of EPO,” the CCES said on its website.
Papillon, a former Canadian U23 road champion, waived his right to a hearing and accepted the proposed two-year suspension commencing August 12, 2011, CCES continued.
“It is always disappointing when we find that an athlete has attempted to cheat,” said Paul Melia, president and CEO of CCES. “However, it is even more disconcerting when we find out that the substance being used is as dangerous and sophisticated as EPO.”
In a letter sent to the Veloptimum website. Papillon wrote: “I do not deny the decision which I took and I take full responsibility for it. I admit having done something unacceptable and I regret it. I apologize for the disappointment that I cause to those who put their trust in me, notably those close to me, my coach and the members of my team.”